Precedent Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
BCWM
SMDAM
Precedent Wealth Partners's AMGN Position: Q2 2026 in Review
Precedent Wealth Partners reduced its Amgen (AMGN) stake by 78% in Q2 2026, selling an estimated $2.18M and leaving 1,788 shares worth $647K. The position accounts for 0.11% of the portfolio, ranked #131.
Precedent Wealth Partners first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.87M in Q1 2026. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Precedent Wealth Partners held 1,788 shares of Amgen worth $647K as of Q2 2026.
- Precedent Wealth Partners sold 6,358 Amgen shares in Q2 2026, an estimated $2.18M.
- Amgen made up 0.11% of Precedent Wealth Partners's portfolio in Q2 2026, its #131 holding.
- Precedent Wealth Partners first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
- Precedent Wealth Partners's Amgen position peaked at $2.87M in Q1 2026.
- 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Precedent Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.